Dale Sanders, Chief Technology Officer at Health Catalyst, Inc. (HCAT), sold 27,500 shares at $26.97 ($742K) on 2020-06-01, disclosed to the SEC on 2020-06-03.
Open-market sale of $742k HCAT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HCAT | SELL | 2020-07-06 | $795K | — | Filing → |
| HCAT | SELL | 2020-05-05 | $698K | — | Filing → |
| HCAT | SELL | 2020-04-03 | $1.4M | — | Filing → |